201 related articles for article (PubMed ID: 31346674)
21. Outcomes with image-based interstitial brachytherapy for vaginal cancer.
Manuel MM; Cho LP; Catalano PJ; Damato AL; Miyamoto DT; Tempany CM; Schmidt EJ; Viswanathan AN
Radiother Oncol; 2016 Sep; 120(3):486-492. PubMed ID: 27321150
[TBL] [Abstract][Full Text] [Related]
22. From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications.
Guinot JL; Arribas L; Tortajada MI; Crispín V; Carrascosa M; Santos M; Mut A; Vendrell JB; Pesudo C; Chust ML
Brachytherapy; 2013; 12(6):528-34. PubMed ID: 23850275
[TBL] [Abstract][Full Text] [Related]
23. Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation.
Yoon SM; Suh R; Abtin F; Moghanaki D; Genshaft S; Kamrava M; Drakaki A; Liu S; Venkat P; Lee A; Chang AJ
Radiat Oncol; 2021 Jun; 16(1):99. PubMed ID: 34098977
[TBL] [Abstract][Full Text] [Related]
24. Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival.
Seidensticker R; Damm R; Enge J; Seidensticker M; Mohnike K; Pech M; Hass P; Amthauer H; Ricke J
BMC Cancer; 2018 Sep; 18(1):882. PubMed ID: 30200921
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness and safety of computed tomography-guided high-dose-rate brachytherapy in treating recurrent hepatocellular carcinoma not amenable to repeated resection or radiofrequency ablation.
Auer TA; Anhamm M; Böning G; Fehrenbach U; Schöning W; Lurje G; Gebauer B; Collettini F
Eur J Surg Oncol; 2024 May; 50(7):108429. PubMed ID: 38788357
[TBL] [Abstract][Full Text] [Related]
26. CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma.
Collettini F; Schreiber N; Schnapauff D; Denecke T; Wust P; Schott E; Hamm B; Gebauer B
Strahlenther Onkol; 2015 May; 191(5):405-12. PubMed ID: 25404063
[TBL] [Abstract][Full Text] [Related]
27. MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life.
Maenhout M; Peters M; Moerland MA; Meijer RP; van den Bosch MAAJ; Frank SJ; Nguyen PL; van Vulpen M; van der Voort van Zyp JRN
Radiother Oncol; 2018 Dec; 129(3):554-560. PubMed ID: 30131183
[TBL] [Abstract][Full Text] [Related]
28. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric feasibility of ablative dose escalated focal monotherapy with MRI-guided high-dose-rate (HDR) brachytherapy for prostate cancer.
Hosni A; Carlone M; Rink A; Ménard C; Chung P; Berlin A
Radiother Oncol; 2017 Jan; 122(1):103-108. PubMed ID: 27916416
[TBL] [Abstract][Full Text] [Related]
30. Treatment of metastatic, imatinib refractory, gastrointestinal stroma tumor with image-guided high-dose-rate interstitial brachytherapy.
Omari J; Drewes R; Matthias M; Mohnike K; Seidensticker M; Seidensticker R; Streitparth T; Ricke J; Powerski M; Pech M
Brachytherapy; 2019; 18(1):63-70. PubMed ID: 30385116
[TBL] [Abstract][Full Text] [Related]
31. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566
[TBL] [Abstract][Full Text] [Related]
32. CT-guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies.
Wieners G; Pech M; Rudzinska M; Lehmkuhl L; Wlodarczyk W; Miersch A; Hengst S; Felix R; Wust P; Ricke J
Eur Radiol; 2006 Nov; 16(11):2586-93. PubMed ID: 16625347
[TBL] [Abstract][Full Text] [Related]
33. Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.
Wedde TB; Småstuen MC; Brabrand S; Fosså SD; Kaasa S; Tafjord G; Russnes KM; Hellebust TP; Lilleby W
Radiother Oncol; 2019 Mar; 132():211-217. PubMed ID: 30389241
[TBL] [Abstract][Full Text] [Related]
34. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
[TBL] [Abstract][Full Text] [Related]
35. High dose rate brachytherapy boost for prostate cancer: Biochemical control and the impact of transurethral resection of the prostate and hydrogel spacer insertion on toxicity outcomes.
Chao M; Bolton D; Lim Joon D; Chan Y; Lawrentschuk N; Ho H; Spencer S; Wasiak J; Guerrieri M; Ow D; Troy A; Pham T; Sengupta S; Tan A; McMillan K; Koufogiannis G; Foroudi F; Ng M; Khoo V
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):415-421. PubMed ID: 30908894
[TBL] [Abstract][Full Text] [Related]
36. Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients.
Marina O; Gustafson GS; Kestin LL; Brabbins DS; Chen PY; Ye H; Martinez AA; Ghilezan MI; Wallace M; Krauss DJ
Brachytherapy; 2014; 13(1):59-67. PubMed ID: 23871661
[TBL] [Abstract][Full Text] [Related]
37. Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy.
Stechele M; Link H; Hirner-Eppeneder H; Alunni-Fabbroni M; Wildgruber M; Salvermoser L; Corradini S; Schinner R; Ben Khaled N; Rössler D; Galun E; Goldberg SN; Ricke J; Kazmierczak PM
Radiat Oncol; 2023 Jul; 18(1):125. PubMed ID: 37507808
[TBL] [Abstract][Full Text] [Related]
38. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
39. Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome.
Jiang P; van der Horst C; Kimmig B; Zinsser F; Poppe B; Luetzen U; Juenemann KP; Dunst J; Siebert FA
Brachytherapy; 2017; 16(1):186-192. PubMed ID: 28341011
[TBL] [Abstract][Full Text] [Related]
40. Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function.
Senger C; Conti A; Kluge A; Pasemann D; Kufeld M; Acker G; Lukas M; Grün A; Kalinauskaite G; Budach V; Waiser J; Stromberger C
BMC Urol; 2019 Oct; 19(1):96. PubMed ID: 31638979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
